If the Pfizer-involved COVID-19 vaccine is successful in beating the spread of the pandemic that has gripped the nation for nearly 10 months, it will to some extent be due to the efforts of myriad Connecticut-based scientists and clinical trial volunteers.
Pfizer has reported that its COVID-19 vaccine, partly developed in Connecticut, showed more than 90 percent effectiveness in the first weeks of clinical trials, raising hopes for an end to a coronavirus scourge that has claimed more than 1 million lives and gripped the world in recession.
The recent developments show that the drug development system is working, according to an op-ed in The Washington Post.
article in the New Haven Register
article in the Connecticut Post
op-ed in the Washington Post